Oncolix, Inc.
CIK 0001584137
Revenue (TTM)
$19.82K
Q3 Nov 2018
Net Income (TTM)
−$6.78M
−142.2% YoY
Q3 Nov 2018
EPS Diluted (TTM)
—
Q3 Nov 2018
Gross Margin
—
Q3 Nov 2018
Operating Margin
-451.6%
Q3 Nov 2018
Net Margin
-34,232.9%
Q3 Nov 2018
Free Cash Flow (TTM)
—
Q3 Nov 2018
Cash
$123.3K
Q3 Nov 2018
Total Debt
—
Q3 Nov 2018
Shares Outstanding
114.23M sh
Q3 Nov 2018
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.